The Endothelial Glycocalyx as a Target of Excess Soluble Fms-like Tyrosine Kinase-1.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
11 Mar 2023
Historique:
received: 13 02 2023
revised: 08 03 2023
accepted: 09 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Soluble fms-like tyrosine kinase-1 (sFlt-1) is a secreted protein that binds heparan sulfate expressed on the endothelial glycocalyx (eGC). In this paper we analyze how excess sFlt-1 causes conformational changes in the eGC, leading to monocyte adhesion, a key event triggering vascular dysfunction. In vitro exposure of primary human umbilical vein endothelial cells to excess sFlt-1 decreased eGC height and increased stiffness as determined by atomic force microscopy (AFM). Yet, structural loss of the eGC components was not observed, as indicated by Ulex europaeus agglutinin I and wheat germ agglutinin staining. Moreover, the conformation observed under excess sFlt-1, a collapsed eGC, is flat and stiff with unchanged coverage and sustained content. Functionally, this conformation increased the endothelial adhesiveness to THP-1 monocytes by about 35%. Heparin blocked all these effects, but the vascular endothelial growth factor did not. In vivo administration of sFlt-1 in mice also resulted in the collapse of the eGC in isolated aorta analyzed ex vivo by AFM. Our findings show that excess sFlt-1 causes the collapse of the eGC and favors leukocyte adhesion. This study provides an additional mechanism of action by which sFlt-1 may cause endothelial dysfunction and injury.

Identifiants

pubmed: 36982455
pii: ijms24065380
doi: 10.3390/ijms24065380
pmc: PMC10049398
pii:
doi:

Substances chimiques

Vascular Endothelial Growth Factor Receptor-1 EC 2.7.10.1
Vascular Endothelial Growth Factor A 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : SE2824/3-1
Organisme : Deutsche Forschungsgemeinschaft
ID : KFO 342 - ZA428/18-1

Références

J Am Heart Assoc. 2019 Feb 19;8(4):e010647
pubmed: 30764695
Biotechnol Appl Biochem. 2001 Dec;34(3):199-204
pubmed: 11730488
Sci Rep. 2018 May 15;8(1):7581
pubmed: 29765073
Cardiovasc Res. 2011 Feb 15;89(3):671-9
pubmed: 21139021
Biophys J. 2019 Feb 19;116(4):694-708
pubmed: 30736980
J Am Soc Nephrol. 2009 Oct;20(10):2235-45
pubmed: 19608702
Am J Hematol. 2020 Aug;95(8):E188-E191
pubmed: 32472588
PLoS One. 2013 Nov 20;8(11):e80905
pubmed: 24278345
J Cell Sci. 2003 Sep 1;116(Pt 17):3479-89
pubmed: 12865438
Obstet Gynecol. 2007 Jun;109(6):1368-74
pubmed: 17540809
Trends Pharmacol Sci. 2017 Apr;38(4):322-338
pubmed: 28214012
Cell. 1997 Nov 28;91(5):695-704
pubmed: 9393862
Sci Rep. 2017 Apr 13;7:46476
pubmed: 28406245
J Am Soc Nephrol. 2012 Nov;23(11):1900-8
pubmed: 23085635
PLoS One. 2012;7(7):e41520
pubmed: 22844486
J Biol Chem. 2005 Mar 18;280(11):10234-43
pubmed: 15632175
Biochem Biophys Res Commun. 1999 Nov 2;264(3):730-4
pubmed: 10544000
J Immunol. 2015 Aug 1;195(3):1152-61
pubmed: 26101325
Phys Rev Lett. 2018 May 11;120(19):198001
pubmed: 29799224
Blood. 2008 Apr 1;111(7):3479-88
pubmed: 18184864
J Chem Inf Model. 2021 Aug 23;61(8):3891-3898
pubmed: 34278794
Front Physiol. 2020 Jun 18;11:684
pubmed: 32625119
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
J Clin Invest. 2016 Jul 1;126(7):2561-74
pubmed: 27270170
Structure. 2017 Feb 7;25(2):341-352
pubmed: 28111021
FEBS J. 2022 Jan;289(1):183-198
pubmed: 34252269
Biochem Biophys Res Commun. 1996 Sep 13;226(2):324-8
pubmed: 8806634
Int J Mol Sci. 2021 Jan 19;22(2):
pubmed: 33478148
Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):272-9
pubmed: 25538208
Science. 2021 Aug 20;373(6557):871-876
pubmed: 34282049
Front Physiol. 2011 Oct 04;2:62
pubmed: 22007175
J Vis Exp. 2015 Jul 23;(101):e53057
pubmed: 26273955
Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2972-4
pubmed: 21979436
Sci Rep. 2019 Dec 3;9(1):18209
pubmed: 31796790
Circulation. 2011 Dec 6;124(23):2543-53
pubmed: 22082677
Sci Rep. 2017 Aug 25;7(1):9444
pubmed: 28842629
Front Immunol. 2021 Nov 30;12:789142
pubmed: 34917096
Pflugers Arch. 2011 Oct;462(4):519-28
pubmed: 21796337
Am J Physiol Cell Physiol. 2021 Feb 1;320(2):C216-C224
pubmed: 33326314
Nanomedicine. 2015 Aug;11(6):1521-30
pubmed: 25881741
Adv Colloid Interface Sci. 2014 Jun;208:161-76
pubmed: 24674656
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Basic Res Cardiol. 2015 May;110(3):30
pubmed: 25893874
Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10705-9
pubmed: 8248162
Circ Res. 2011 Apr 29;108(9):1063-70
pubmed: 21415391
J Immunol. 1989 Mar 15;142(6):1970-6
pubmed: 2784145
Atherosclerosis. 2014 Jun;234(2):335-43
pubmed: 24727235
Kidney Int. 2020 Mar;97(3):502-515
pubmed: 32008804
J Am Coll Cardiol. 2011 Jul 19;58(4):386-94
pubmed: 21757116
Biol Sex Differ. 2020 Jun 29;11(1):34
pubmed: 32600401
PLoS One. 2014 Jan 21;9(1):e85258
pubmed: 24465515
Int J Mol Sci. 2022 Dec 16;23(24):
pubmed: 36555698
Cell. 2012 Oct 12;151(2):384-99
pubmed: 23063127
J Cell Biol. 1993 Mar;120(6):1371-80
pubmed: 8449983
J Clin Med Res. 2018 Sep;10(9):700-706
pubmed: 30116440
Kidney Int. 2019 May;95(5):1091-1102
pubmed: 30824181
Nature. 2006 Oct 26;443(7114):993-7
pubmed: 17051153
J Am Soc Nephrol. 2021 Aug;32(8):1853-1863
pubmed: 34155060
Am J Pathol. 2020 Apr;190(4):732-741
pubmed: 32035884
J Biol Chem. 2004 Oct 1;279(40):41734-43
pubmed: 15292271
J Clin Invest. 2003 Mar;111(5):649-58
pubmed: 12618519
Antioxid Redox Signal. 2019 Mar 1;30(7):945-959
pubmed: 29433330
Int J Biochem Cell Biol. 2001 Apr;33(4):409-20
pubmed: 11312109
J Matern Fetal Neonatal Med. 2022 Dec;35(25):7466-7470
pubmed: 34238103
Cell Mol Bioeng. 2016 Aug 25;10(1):102-113
pubmed: 31719852
Front Med (Lausanne). 2022 May 09;9:894633
pubmed: 35615097
Front Pharmacol. 2020 Jan 21;10:1568
pubmed: 32038245

Auteurs

Annika Schulz (A)

Department of Internal Medicine D, University Hospital Münster, 48149 Münster, Germany.

Carolin C Drost (CC)

Department of Internal Medicine D, University Hospital Münster, 48149 Münster, Germany.

Bettina Hesse (B)

Department of Internal Medicine D, University Hospital Münster, 48149 Münster, Germany.

Katrin Beul (K)

Department of Internal Medicine D, University Hospital Münster, 48149 Münster, Germany.

Göran R Boeckel (GR)

Department of Internal Medicine D, University Hospital Münster, 48149 Münster, Germany.

Alexander Lukasz (A)

Department of Internal Medicine D, University Hospital Münster, 48149 Münster, Germany.

Hermann Pavenstädt (H)

Department of Internal Medicine D, University Hospital Münster, 48149 Münster, Germany.

Marcus Brand (M)

Department of Internal Medicine D, University Hospital Münster, 48149 Münster, Germany.

Giovana S Di Marco (GS)

Department of Internal Medicine D, University Hospital Münster, 48149 Münster, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH